Correlation Between Passage Bio and Iteos Therapeutics
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Iteos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Iteos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Iteos Therapeutics, you can compare the effects of market volatilities on Passage Bio and Iteos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Iteos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Iteos Therapeutics.
Diversification Opportunities for Passage Bio and Iteos Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Passage and Iteos is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Iteos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iteos Therapeutics and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Iteos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iteos Therapeutics has no effect on the direction of Passage Bio i.e., Passage Bio and Iteos Therapeutics go up and down completely randomly.
Pair Corralation between Passage Bio and Iteos Therapeutics
Given the investment horizon of 90 days Passage Bio is expected to under-perform the Iteos Therapeutics. In addition to that, Passage Bio is 2.2 times more volatile than Iteos Therapeutics. It trades about -0.18 of its total potential returns per unit of risk. Iteos Therapeutics is currently generating about -0.12 per unit of volatility. If you would invest 893.00 in Iteos Therapeutics on August 27, 2024 and sell it today you would lose (61.00) from holding Iteos Therapeutics or give up 6.83% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Passage Bio vs. Iteos Therapeutics
Performance |
| Timeline |
| Passage Bio |
| Iteos Therapeutics |
Passage Bio and Iteos Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Passage Bio and Iteos Therapeutics
The main advantage of trading using opposite Passage Bio and Iteos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Iteos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iteos Therapeutics will offset losses from the drop in Iteos Therapeutics' long position.| Passage Bio vs. Eliem Therapeutics | Passage Bio vs. HCW Biologics | Passage Bio vs. Scpharmaceuticals | Passage Bio vs. Milestone Pharmaceuticals |
| Iteos Therapeutics vs. Eliem Therapeutics | Iteos Therapeutics vs. HCW Biologics | Iteos Therapeutics vs. Scpharmaceuticals | Iteos Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |